Senior insider sale
ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$2.95M
50K shares
What this filing means
MAIER PAUL V plans to sell 50K shares of ETON PHARMACEUTICALS, INC. valued at approximately $2.95M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/28/2026ACC: 0001974078-26-000335
50K
Shares to sell
$2.95M
Approx. market value
50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
stock options
cash
8/28/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/28/2026 | stock options cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
50K
Market value
$2.95M
8/28/2026
Total
Units
50K
Value
$2.95M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/28/2026 | 50K | $2.95M | Nasdaq | Planned |
| Total | 50K | $2.95M | ||